About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Pfizer Drug Shows Promise in Slowing Down Breast Cancer Progression

by Kathy Jones on April 8, 2014 at 10:36 PM
Font : A-A+

 Pfizer Drug Shows Promise in Slowing Down Breast Cancer Progression

Experts suggest that an experimental cancer drug developed by Pfizer could provide a potential treatment in slowing down the spread of advanced breast cancer.

The drug, called palbociclib, when administered with another anti-cancer drug already on the market, letrozole, stopped cancer progression for a median of 20 months.

Advertisement

That was double the amount of time seen in a control group of patients who did not receive palbociclib.

However, those on the two drugs survived an average of four months longer (37.5 months versus 33.3 months), which was not a statistically significant gain, the researchers noted.
Advertisement

More research is ongoing to measure the potential impact of the drug as a treatment for estrogen receptor positive and HER2 negative breast cancer.

The findings of the phase II trial, which included 165 women, were released Sunday at the American Association of Cancer Research in San Diego, California.

Source: AFP
Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Pfizer Drug Shows Promise in Slowing Down Breast Cancer Progression Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests